Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

NCT05910827

Conditions
Advanced Cutaneous Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +21 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
View all 20 locations
View Trial Details
Recruiting

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

NCT07099898

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • GSK Investigational Site Mar del Plata, Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aire, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aire, Argentina
View all 120 locations
View Trial Details
Recruiting

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

NCT07079475

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Harbin Cancer Hospital Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 17 locations
View Trial Details
Recruiting

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

NCT06731907

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Kentucky ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • Sanford Fargo Medical Center ( Site 0039) Fargo, North Dakota, United States
  • Abramson Cancer Center ( Site 0010) Philadelphia, Pennsylvania, United States
View all 41 locations
View Trial Details
Recruiting

A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy

NCT07375316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University Guangzhou, Guangdong, China
  • Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences Meizhou, Guangdong, China
  • The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China
  • Peking University Shenzhen Hospital Shenzhen, Guangdong, China
View Trial Details
Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

NCT07278479

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • United Theranostics Glen Burnie, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • United Theranostics Princeton, New Jersey, United States
View Trial Details

Related conditions